Souhaitez-vous accéder aux communiqués récents ?

First patient dosed in Phase 3 LUTEON1 trial evaluating TLX250-Tx in relapsed or recurrent clear cell renal cell carcinoma (ccRCC).LUTEON is the first Phase 3 study of a CAIX2-targeted...

SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a biotechnology company pioneering the development of targeted genetic...

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experienceCory Anderson promoted to Executive Vice President and General...

SAN JOSE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”; “Rani” or the “Company”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused...

MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...

Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...

Cosmos Health expands Pharma Cell partnership in Albania with annualized orders exceeding 54,000 units.

MONTRÉAL, 20 juill. 2026 (GLOBE NEWSWIRE) -- La Cour suprême du Canada a rendu sa décision très attendue dans l’affaire Pharmascience Inc. c. Janssen Inc., qui porte sur la validité du brevet...

MONTREAL, July 20, 2026 (GLOBE NEWSWIRE) -- The Supreme Court of Canada released its highly anticipated decision in Pharmascience Inc. v. Janssen Inc., which addresses the validity of Janssen’s...

Au premier semestre 2026, le chiffre d'affaires atteint 768 M€ : +7,4 % à PCC par rapport au premier semestre 2025+4,0 % à taux réels, impacté par des effets de change défavorables Une croissance...